Litcius/Paper detail

The role of long non‐coding <scp>RNAs</scp> in drug resistance of cancer

He‐da Zhang, Linhong Jiang, Shanliang Zhong, Jian Li, Dawei Sun, Junchen Hou, Dandan Wang, Siying Zhou, Jinhai Tang

2020Clinical Genetics19 citationsDOI

Abstract

Long non-coding RNAs (lncRNAs), a class of long RNAs, are longer than 200 nucleotides in length but lack protein-coding capacity. LncRNAs, as critical genomic regulators, are involved in genomic imprinting regulation, histone modification and gene expression regulation as well as tumor initiation and progression. However, it is also found that lncRNAs are associated with drug resistance in several types of cancer. Drug resistance is an important reason for clinical chemotherapy failure, and the molecular mechanism of tumor resistance is complex, which is a process of multi-cause, multi-gene and multi-signal transduction pathway interaction. Then comprehending the mechanisms of chemoresistance will help find ways to control the tumor progression effectively. Therefore, in this review, we will construct lncRNAs /drug resistance interaction network and shed light on the role of lncRNAs in drug resistance.

Topics & Concepts

Drug resistanceCoding (social sciences)GeneticsLong non-coding RNADrugBiologyCancer researchComputational biologyGeneRNAPharmacologyMathematicsStatisticsCancer-related molecular mechanisms researchCircular RNAs in diseasesRNA modifications and cancer